HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea · Delayed Price · Currency is KRW 3,280.00
-60.00 (-1.80%)
Oct 29, 2026, 3:30 PM KST
HLB Life Science Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 54,399 | 45,752 | 32,771 | 97,990 | 99,591 | 53,494 |
Revenue Growth | 37.87% | 39.61% | -66.56% | -1.61% | 86.17% | -41.73% |
Gross Profit Gross Profit Growth | -2,952 | -721.6 | -3,634 | -925.04 | -3,222 | -5,661 |
Operating Income Operating Income Growth | -22,674 | -21,035 | -19,984 | -25,493 | -19,950 | -18,329 |
Net Income Net Income Growth | -33,108 | -99,794 | 6,138 | -5,983 | -54,277 | -49,152 |
Earnings Per Share EPS Growth | -272.17 | -819.37 | 54.46 | -59.00 | -537.56 | -494.76 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Other Growth | 8,894 | 6,102 | 5,860 | 4,992 | 5,167 | 4,545 |
Medicare Division Medicare Division Growth | 39,169 | 35,127 | 28,017 | 30,187 | 35,785 | - |
Bio Development Bio Development Growth | 356.94 | 358.95 | 788.51 | 425.99 | 312.98 | 12.68 |
Construction and Engineering Construction and Engineering Growth | 7,121 | 5,346 | 1,007 | 1,362 | 5,886 | 11,575 |
Internal Sales Internal Sales Growth | - | -1,182 | -2,902 | -2,393 | -1,618 | -372.94 |
Total Total Growth | 54,358 | 45,752 | 32,771 | 97,990 | 99,591 | 53,494 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 14,578 | 13,878 | 79,566 | 78,860 | 131,989 | 139,961 |
Total Debt Total Debt Growth | 159,246 | 160,357 | 123,783 | 166,578 | 147,473 | 4,621 |
Net Cash (Debt) Net Cash Growth | -144,668 | -146,479 | -44,217 | -87,718 | -15,484 | 135,340 |
Net Cash Growth | - | - | - | - | - | -7.71% |
Net Cash Per Share Net Cash Per Share Growth | -1187.95 | -1202.24 | -392.35 | -861.84 | -153.36 | 1362.33 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -26,609 | -22,933 | -32,005 | -10,016 | -29,744 | -14,084 |
Capital Expenditures CapEx Growth | -14,790 | -25,582 | -27,296 | -20,618 | -10,676 | -2,421 |
Free Cash Flow Free Cash Flow Growth | -41,399 | -48,515 | -59,301 | -30,634 | -40,420 | -16,505 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -5.43% | -1.58% | -11.09% | -0.94% | -3.23% | -10.58% |
Operating Margin | -41.68% | -45.98% | -60.98% | -26.02% | -20.03% | -34.26% |
Pretax Margin | -61.84% | -219.81% | 11.14% | -6.64% | -61.09% | -100.24% |
Profit Margin | -60.86% | -218.12% | 18.73% | -6.11% | -54.50% | -91.88% |
FCF Margin | -76.10% | -106.04% | -180.96% | -31.26% | -40.59% | -30.85% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 198.66 | - | - | - |
PS Ratio | 7.48 | 10.32 | 37.21 | 11.90 | 10.82 | 22.23 |